Robertson, Nathan
Rappas, Mathieu
Doré, Andrew S.
Brown, Jason
Bottegoni, Giovanni
Koglin, Markus
Cansfield, Julie
Jazayeri, Ali
Cooke, Robert M.
Marshall, Fiona H.
Article History
Received: 9 June 2017
Accepted: 7 November 2017
First Online: 4 January 2018
Competing interests
: The authors are employees of Heptares Therapeutics and are shareholders of Sosei Group, the parent company of Heptares. Heptares is a drug discovery and development company working in the field of G-protein-coupled receptor structure-based drug design.